Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Gain Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
Revenues0.10.20.00.00.0
            Revenue growth-15.1%471.3%-30.1%100.4% 
Cost of goods sold17.90.00.01.60.8
Gross profit-17.80.20.0-1.5-0.8
            Gross margin-12688.1%100.0%100.0%-3740.7%-3912.2%
Research and development 7.22.3  
General and administrative9.56.81.20.60.2
EBIT-17.8-13.8-3.5-2.1-1.0
            EBIT margin-12688.1%-8379.8%-12047.5%-5084.9%-4989.7%
Pre-tax income-17.5-13.9-3.6-2.2-1.1
Income taxes0.10.00.00.00.0
Net income-17.6-13.9-3.6-2.2-1.1
            Net margin-12555.1%-8418.9%-12387.7%-5310.9%-5364.4%
 
Diluted EPS($1.48)($1.37)($1.33)($0.97)($0.49)
Shares outstanding (diluted)11.910.22.72.32.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy